International Stem Cell (ISCO) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $966000.0.
- International Stem Cell's Cash & Current Investments fell 2609.03% to $966000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $966000.0, marking a year-over-year decrease of 2609.03%. This contributed to the annual value of $1.2 million for FY2024, which is 2254.41% down from last year.
- Latest data reveals that International Stem Cell reported Cash & Current Investments of $966000.0 as of Q3 2025, which was down 2609.03% from $920000.0 recorded in Q2 2025.
- International Stem Cell's Cash & Current Investments' 5-year high stood at $1.6 million during Q4 2023, with a 5-year trough of $171000.0 in Q4 2021.
- Over the past 5 years, International Stem Cell's median Cash & Current Investments value was $966000.0 (recorded in 2025), while the average stood at $991000.0.
- As far as peak fluctuations go, International Stem Cell's Cash & Current Investments crashed by 7518.14% in 2021, and later skyrocketed by 33391.81% in 2022.
- Over the past 5 years, International Stem Cell's Cash & Current Investments (Quarter) stood at $171000.0 in 2021, then surged by 333.92% to $742000.0 in 2022, then soared by 114.02% to $1.6 million in 2023, then fell by 22.54% to $1.2 million in 2024, then decreased by 21.46% to $966000.0 in 2025.
- Its Cash & Current Investments was $966000.0 in Q3 2025, compared to $920000.0 in Q2 2025 and $1.5 million in Q1 2025.